KNTPF
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Sep 30 closing price
Capitalization
116.15M
Intraday Buy/Sell Signals
MLEC
Price
$0.66
Change
+$0.01 (+1.54%)
Updated
Oct 20 closing price
Capitalization
7.2M
6 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

KNTPF vs MLEC

Header iconKNTPF vs MLEC Comparison
Open Charts KNTPF vs MLECBanner chart's image
KINTOR PHARMACEUTICAL
Price$0.27
Change+$0.01 (+3.85%)
Volume$200
Capitalization116.15M
Moolec Science SA
Price$0.66
Change+$0.01 (+1.54%)
Volume$70.71K
Capitalization7.2M
KNTPF vs MLEC Comparison Chart in %
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNTPF vs. MLEC commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTPF is a Hold and MLEC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (KNTPF: $0.27 vs. MLEC: $0.66)
Brand notoriety: KNTPF and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTPF: 60% vs. MLEC: 30%
Market capitalization -- KNTPF: $116.15M vs. MLEC: $7.2M
KNTPF [@Biotechnology] is valued at $116.15M. MLEC’s [@Biotechnology] market capitalization is $7.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTPF’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 1 green FA rating(s).

  • KNTPF’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 1 green, 4 red.
According to our system of comparison, KNTPF is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNTPF’s TA Score shows that 3 TA indicator(s) are bullish while MLEC’s TA Score has 4 bullish TA indicator(s).

  • KNTPF’s TA Score: 3 bullish, 3 bearish.
  • MLEC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MLEC is a better buy in the short-term than KNTPF.

Price Growth

KNTPF (@Biotechnology) experienced а 0.00% price change this week, while MLEC (@Biotechnology) price change was -11.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.62%. For the same industry, the average monthly price growth was +17.01%, and the average quarterly price growth was +69.82%.

Reported Earning Dates

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+3.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($116M) has a higher market cap than MLEC($7.21M). KNTPF YTD gains are higher at: 68.000 vs. MLEC (-91.875).
KNTPFMLECKNTPF / MLEC
Capitalization116M7.21M1,610%
EBITDAN/A-5.24M-
Gain YTD68.000-91.875-74%
P/E RatioN/AN/A-
RevenueN/A7.83M-
Total CashN/A926K-
Total DebtN/A22.1M-
TECHNICAL ANALYSIS
Technical Analysis
KNTPFMLEC
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
43%
Bullish Trend 4 days ago
51%
Momentum
ODDS (%)
Bullish Trend 4 days ago
30%
Bearish Trend 4 days ago
60%
MACD
ODDS (%)
Bullish Trend 4 days ago
33%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
34%
Bearish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
29%
Bearish Trend 4 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 28 days ago
59%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMAX2.840.09
+3.27%
Powell Max Limited
OMC77.520.31
+0.40%
Omnicom Group
NUS10.690.03
+0.28%
NuSkin Enterprises
UNFI42.060.07
+0.17%
United Natural Foods
ILLR0.65-0.06
-7.91%
Triller Group Inc

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
MLEC - KNTPF
27%
Poorly correlated
-4.41%
KNSA - KNTPF
20%
Poorly correlated
-0.72%
UNCY - KNTPF
20%
Poorly correlated
-4.46%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
-3.81%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
-4.41%
SPRB - MLEC
51%
Loosely correlated
+0.77%
CTMX - MLEC
42%
Loosely correlated
-2.44%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
-1.65%
ABVC - MLEC
31%
Poorly correlated
N/A
More